Related Experiment Videos
[Clinical experience with cefminox in the pediatric field]
Insights
Cefminox (CMNX) effectively treated bacterial infections in 20 pediatric patients. This antibiotic demonstrated good clinical response and bacteriological effectiveness with minimal side effects, proving useful in pediatric care.
Area of Science:
- Pediatric Infectious Diseases
- Bacteriology
- Pharmacology
Background:
- Acute bacterial infections pose a significant health challenge in pediatric populations.
- The need for effective and safe antibiotic treatments in children is critical.
Purpose of the Study:
- To evaluate the clinical efficacy and safety of Cefminox (CMNX) in treating various acute bacterial infections in pediatric patients.
- To assess the bacteriological effectiveness of Cefminox against common bacterial pathogens.
Main Methods:
- Intravenous administration of Cefminox (CMNX) to 20 pediatric patients.
- Infections treated included bronchopneumonia, urinary tract infections, staphylococcal scalded skin syndrome, and others.
- Clinical response and bacteriological eradication were monitored.
Main Results:
- Good clinical response observed in 18 out of 20 patients (90%).
- Bacteriological effectiveness achieved in 13 out of 14 strains (93%).
- Minimal adverse effects noted: one case of diarrhea and one with transient elevation of liver enzymes (GOT/GPT).
Conclusions:
- Cefminox (CMNX) is a valuable antibiotic for treating a range of bacterial infections in children.
- The drug exhibits a favorable safety profile and high efficacy in the pediatric population.
- Further investigation into Cefminox's role in pediatric infectious disease management is warranted.
Abstract:
Cefminox (CMNX, MT-141) was given intravenously to 20 children with the following acute bacterial infections; 10 cases of bronchopneumonia, 4 cases of urinary tract infection, 2 cases of staphylococcal scalded skin syndrome, each 1 case of acute pharyngitis, acute tonsillitis, purulent cervical lymphadenitis and acute tonsillitis, and pleuritis. Good clinical responses were obtained in 18 patients out of 20 patients and bacteriological effectiveness in 13 strains out of 14 strains. No side effect was observed except for 1 case with diarrhea and 1 case with slight elevation of GOT and GPT. From the above clinical results, it is apparent that CMNX is a useful antibiotic for treating pediatric patients with various kinds of bacterial infections.